ALA 2.70% 19.0¢ arovella therapeutics limited

Ann: Anagrelide Cancer Patent For Japan, page-11

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,039 Posts.
    lightbulb Created with Sketch. 788
    theoc: Thanks a lot for your reply!! Obviously, a kind of very 'narrow' path for company survival ahead.... Will need a lot of luck for sure. Long-term holders will NEVER ever see their money back unless they are willing to invest further funds into much lower CR's levels than in the past, which will be still a risky endeavour for certain (the old saying of "throw good money after bad" comes to mind perhaps?).

    And, yes, for brand NEW investors here perhaps an attractive PUNT for sure! A high risk/high reward (or loss) play for certain.
    Best of luck to the newcomers - as long-term holders are already toasted.

    wasa
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
0.005(2.70%)
Mkt cap ! $200.6M
Open High Low Value Volume
18.8¢ 19.0¢ 18.5¢ $115.0K 609.6K

Buyers (Bids)

No. Vol. Price($)
6 226209 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 791369 7
View Market Depth
Last trade - 15.59pm 08/11/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.